Vaxcyte, Inc.: Fourth Quarter and Full Year 2024 Financial Results and Business Update On February 12, 2025, Vaxcyte, Inc., a clinical-stage vaccine innovation company, announced that it will release its financial results for the fourth quarter and full year 2024 after market close on February 25, 2025. This announcement comes as the company continues to…
OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants Exciting News in Pediatric Orthopedics WARSAW, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) has recently made a significant announcement that has captured the attention of the medical community and investors alike. The Company has commenced an…
Singtel Partners with Vonage to Accelerate Global Enterprise Innovation Introduction In a move aimed at driving rapid application development across multiple markets, Singtel has announced a strategic partnership with Vonage, a global leader in cloud communications and a part of Ericsson. This collaboration will leverage Singtel’s industry-leading network, edge, and communications application programming interfaces (APIs)…
Litecoin Surges as Speculation of Spot ETF Approval Grows Litecoin saw a significant increase of 5.15% in its value, reaching $122. This surge was fueled by growing speculation that there is a high chance of a spot ETF approval, with odds as high as 90%. The Impact of ETF Approval on Litecoin If a spot…
Last Friday’s Market Recap So last Friday, the S&P 500 ended the day in a bit of a slump following the US NFP report. And let me tell you, there was a little something for everyone in that report. For the buyers out there, the payrolls number actually beat expectations, which is always a good…
That Rollercoaster Ride Called Bitcoin What a wild ride it’s been for Bitcoin (BTC) lately! Just when we thought we were out of the woods, with Bitcoin rebounding after dropping to a low of $95,346 late on Thursday to reclaim $97,000, we find ourselves back in the thick of it. Price action remains sluggish, and…
Immunovant (IMVT): A Potential Turnaround Story Immunovant, Inc. (IMVT), a clinical-stage biotech company focused on developing and commercializing therapies for the treatment of immune-mediated diseases, has recently found itself in a precarious position in the stock market. With the heavy selling pressure subsiding, IMVT has become technically oversold. What Does It Mean for IMVT to…
The S&P 500 Surges to All-Time Highs Top Tech Companies Drive Market Growth The S&P 500 index has been on a remarkable upward trajectory, nearing a new all-time high. This surge has been largely driven by gains in top tech companies, whose stocks have been performing exceptionally well in recent months. Companies like Apple, Amazon,…
